Literature DB >> 11927760

Ziprasidone treatment of delirium.

Laura Leso1, Thomas L Schwartz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11927760     DOI: 10.1176/appi.psy.43.1.61

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


× No keyword cloud information.
  9 in total

Review 1.  Delirium: where do we stand?

Authors:  Chi-Un Pae; David M Marks; Changsu Han; Ashwin A Patkar; Prakash Masand
Journal:  Curr Psychiatry Rep       Date:  2008-06       Impact factor: 5.285

2.  Use of intramuscular ziprasidone for the control of acute psychosis or agitation in an inpatient geriatric population: an open-label study.

Authors:  Alina R Rais; Kristi Williams; Theodor Rais; Tanvir Singh; Marijo Tamburrino
Journal:  Psychiatry (Edgmont)       Date:  2010-01

3.  Delirium: underrecognized and undertreated.

Authors:  Chi-Un Pae; David M Marks; Changsu Han; Ashwin A Patkar; Prakash Masand
Journal:  Curr Treat Options Neurol       Date:  2008-09       Impact factor: 3.598

Review 4.  Psychotic symptoms in patients with medical disorders.

Authors:  Ashwin A Patkar; Rajnish Mago; Prakash S Masand
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

Review 5.  Delirium and its treatment.

Authors:  Azizah Attard; Gopinath Ranjith; David Taylor
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

6.  Delirium and antipsychotics: a systematic review of epidemiology and somatic treatment options.

Authors:  Joseph D Markowitz; Meera Narasimhan
Journal:  Psychiatry (Edgmont)       Date:  2008-10

Review 7.  Cognitive impairment in patients with AIDS - prevalence and severity.

Authors:  Crystal C Watkins; Glenn J Treisman
Journal:  HIV AIDS (Auckl)       Date:  2015-01-29

8.  Ziprasidone in the treatment of mania in bipolar disorder.

Authors:  Stephen E Nicolson; Charles B Nemeroff
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

9.  A research study review of effectiveness of treatments for psychiatric conditions common to end-stage cancer patients: needs assessment for future research and an impassioned plea.

Authors:  Ralph J Johnson
Journal:  BMC Psychiatry       Date:  2018-04-03       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.